Odne
PrivateLast Round
Series A
Extension
Jun 12, 2025
Total Funding Raised
$14.43M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Odne operates in Healthcare & Life Sciences and is based in Dübendorf. Its latest recorded funding round was a Series A Extension round in June 2025.
Odne is a medical technology company that develops transformative endodontic solutions, including its Root Preservation Therapy (RPT) platform for root canal treatments.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Odne Comparables
Compare Odne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sonendo, Inc. | 85% | |
| EdgeEndo | 85% | |
| Henry Schein, Inc. | 77% |
For institutional investors. Book with your work email.
Odne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 12, 2025 | ||||
| Series A Extension | Mar 13, 2024 | ||||
| Seed | Jun 1, 2022 | ||||
| Debt | Oct 3, 2019 | ||||
| Grant | Nov 7, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Odne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Foundation for Technological Innovation | Debt |
| Plug and Play Tech Center | Series A Extension |
| Hatcher+ | Series A Extension |
| Business Angels Switzerland | Seed |
| N & V Capital | Seed |
| Revere Partners | Seed, Series A Extension |
| Venture Kick | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 89% MoM, reaching 4.5K.
- Oct 1, 2025
Products have received clearance from the U.S. Food and Drug Administration.
For institutional investors. Book with your work email.
Odne Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Odne's valuation, stock price, and market status.
Is Odne a public or private company?
Odne is a private company.
What is the current stock price of Odne?
Odne is a private company, so its shares have no public market price. Caplight tracks Odne's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Odne worth (valuation)?
Valuation information for Odne is not publicly available.
Can I buy Odne stock?
Odne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Odne's last funding round?
Odne's most recent funding round was Series A Extension on June 12, 2025.
Who are the main investors in Odne?
Key investors in Odne include Foundation for Technological Innovation, Revere Partners, N & V Capital AG.
Will Odne IPO soon?
No public IPO plans have been announced for Odne.
How can I track Odne secondary market activity?
Caplight tracks bids, offers, and trades in Odne's shares on secondary markets.